Nodamura virus (NoV) was the first isolated member of the Nodaviridae, and is the type species of the alphanodavirus genus. The alphanodaviruses infect insects; NoV is unique in that it can also lethally infect mammals. Nodaviruses have bipartite positive-sense RNA genomes in which RNA1 encodes the RNA-dependent RNA polymerase and the smaller genome segment, RNA2, encodes the capsid protein precursor. To facilitate the study of NoV, we generated infectious cDNA clones of its two genomic RNAs. Transcription of these NoV1 and NoV2 cDNAs in mammalian cells led to viral RNA replication, protein synthesis, and production of infectious virus. Subgenomic RNA3 was produced during RNA replication and encodes nonstructural proteins B1 and B2 in overlapping ORFs. Site-directed mutagenesis of these ORFs, followed by SDS-PAGE and MALDI-TOF mass spectrometry analyses, showed synthesis of B1 and two forms of B2 (B2-134 and B2-137) during viral replication. We also characterized a point mutation in RNA1 far upstream of the RNA3 region that resulted in decreased RNA3 synthesis and RNA2 replication, and a reduced yield of infectious particles. The ability to reproduce the entire life cycle of this unusual nodavirus from cDNA clones will facilitate further analysis of NoV RNA replication and pathogenesis.
INTRODUCTION
Nodamura virus (NoV) is the type species of the alphanodavirus genus of the Nodaviridae. This family of small riboviruses with bipartite, positive-strand RNA genomes also includes Flock house virus (FHV), Black beetle virus (BBV), Boolarra virus (BoV), and Pariacoto virus (PaV) . In addition to their intrinsic interest, these viruses provide outstanding model systems for the study of RNA replication, virus assembly, and 3D structure (Ball and Johnson, 1998; Schneemann et al., 1998) . All alphanodaviruses infect insects. NoV is unique in that it can also infect suckling mice (Scherer and Hurlbut, 1967) and suckling hamsters (Garzon and Charpentier, 1991) , resulting in paralysis and death. Thus, it is the first arbovirus described that can be lethal for both mammalian and invertebrate organisms (Bailey et al., 1975; Scherer and Hurlbut, 1967) . NoV RNA replication is more thermostable than that of the other family members, consistent with its infectivity for mice and hamsters (Ball et al., 1992) .
NoV (strain Mag115) has been isolated only once, from an inapparent infection of Culex tritaeniorhynchus mosquitoes during a screen for Japanese encephalitis virus in 1956 in Japan. It was identified on the basis of its lethality to suckling mice (Scherer and Hurlbut, 1967; Scherer et al., 1968) . NoV also lethally infects larvae of the greater wax moth Galleria mellonella, adult honeybees (Apis mellifera), and several other mosquito species, including Aedes aegypti, Ae. albopictus, Toxorhynchites amboinensis and C. tarsalis (Bailey and Scott, 1973; Scherer and Hurlbut, 1967; Tesh, 1980) . Pigs near the site of NoV isolation had high levels of NoV neutralizing antibody, suggesting that they may be part of the natural host range of this virus, but no positive human antisera were detected (Scherer et al., 1968) .
NoV infection of cultured baby hamster kidney BHK21 cells has been reported previously, although the results were not consistently reproducible (Bailey et al., 1975; Ball et al., 1992; Garzon et al., 1978; Hiscox and Ball, 1997; Newman and Brown, 1977; Newman et al., 1978) . Infected BHK21 cells exhibit no cytopathic effect (CPE), but they could be used to grow stocks of infectious virus (Bailey et al., 1975; Garzon et al., 1978; Newman and Brown, 1977) . However, analysis of NoV infection in these cells focused entirely on quantitation of infectivity rather than on RNA replication. When introduced by transfection, purified NoV genomic RNAs can replicate in BHK21 cells and a wide range of other cultured mammalian cells (Ball et al., 1992) .
Many of the features of the nodavirus replication cycle have been established by studies of FHV and BBV (reviewed by Ball and Johnson, 1998) . Infectious cDNA clones have long been available for FHV (Dasmahapatra et al., 1986) and have recently been constructed for PaV (Johnson and Ball, 2001 ; and for the betanodavirus Striped Jack nervous necrosis virus (SJNNV; Iwamoto et al., 2001) .
The nodavirus divided genome naturally separates the replicative and packaging functions onto two different positive-sense RNA molecules, RNA1 and RNA2, respectively. Nodavirus genomic RNAs have 5Ј cap structures, while their 3Ј ends lack poly(A) tails and are blocked to chemical and enzymatic modification (Dasmahapatra et al., 1985; Guarino et al., 1984; Kaesberg et al., 1990; Newman and Brown, 1976) . RNA1 and RNA2 are copackaged into the same virion and both are required for infectivity (Newman and Brown, 1977) . RNA1 encodes protein A, the catalytic subunit of the RNA-dependent RNA polymerase (RdRp) that replicates both genome segments. RNA2 encodes the viral capsid protein precursor, ␣, which is cleaved during maturation of the particle into the ␤ and ␥ proteins found in the virion; this cleavage is essential for infectivity (Schneemann et al., 1992) .
During RNA replication, the RdRp also directs the production of subgenomic RNA3, which is 3Ј-coterminal with RNA1. FHV RNA2 and RNA3 are counter-regulatory. FHV RNA2 replication depends on RNA3 synthesis but not on the proteins RNA3 encodes, suggesting a role for RNA3 in the coordination of FHV RNA replication (Eckerle and Ball, 2002) . In contrast, RNA3 synthesis is suppressed by the replication of RNA2 (Zhong and Rueckert, 1993) .
BBV RNA3 (and the identical RNA3 of FHV) encodes two small nonstructural proteins, B1 and B2, in overlapping reading frames (Dasmahapatra et al., 1985) . Previously, only a single RNA3-encoded protein was detected for NoV and PaV, although both B1 and B2 ORFs are present (Ball et al., 1992; Johnson and Ball, 2001; Johnson et al., 2001a) . The function of B1 remains unknown and both BoV and SJNNV lack the B1 ORF altogether (Harper, 1994; Iwamoto et al., 2001) . The FHV B2 protein was shown recently to suppress RNA silencing in plants and cultured Drosophila cells (Li et al., 2002) and is required for wild-type levels of viral replication in Drosophila cells (Harper, 1994; Li et al., 2002) . However, both B2 and B1 are dispensable for FHV RNA replication in mammalian and yeast cells (Ball, 1995; Price et al., 2000) .
We recently reported the sequence of a full-length cDNA clone of NoV RNA1 and compared it to the RNA1 segments of five other nodaviruses, an analysis that revealed the extent of sequence and structural homology among the encoded RdRp's (Johnson et al., 2001a) . A sequence of NoV RNA2 lacking only the 3Ј-terminal dinucleotide has also been published (Dasgupta and Sgro, 1989) .
We report here the construction and characterization of full-length cDNA clones for NoV RNA1 and RNA2. When these clones were transcribed from T7 promoters in BSR T7/5 cells, BHK21 derivatives that constitutively express T7 RNA polymerase (Buchholz et al., 1999) , we reproduced the entire viral infectious cycle, including replication of the genomic RNAs, synthesis of subgenomic RNA3 and viral proteins, and assembly of NoV particles. The infectivity of these particles was assayed in G. mellonella larvae and in BHK21 cells. Mutation of the NoV B1 and B2 ORFs followed by SDS-PAGE and matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) mass spectrometry (MS) analyses showed that B1 was expressed along with two forms of the B2 protein, B2-134 and B2-137.
RESULTS

Determination of terminal sequences and construction of full-length cDNA clones of NoV genomic RNAs
NoV (Mag115 strain, ATCC) was grown in suckling mice and passaged once in infected G. mellonella larvae. Genomic RNAs isolated from these gradient-purified NoV particles were used as templates for first strand cDNA synthesis using random, and later NoV RNA1-specific, primers. These initial clones lacked the extreme 5Ј and 3Ј terminal sequences, which were determined as follows. We transfected BHK21 and BSR T7/5 cells with authentic NoV virion RNA (vRNA) as sources of intracellular replicating RNAs that were then used as templates for 5ЈRACE, primer extension (PE), and junction RT-PCR (see below).
We determined the 5Ј terminal sequences of NoV RNA1 by 5ЈRACE (Table 1) and PE (Fig. 1) , using as templates total cellular RNA isolated from vRNA-transfected BHK21 or BSR T7/5 cells, respectively. For RNA1, The junction RT-PCR sequences were separated into the corresponding 5Ј and 3Ј termini for clarity, using the results of the PE (Fig. 2 ) and 5Ј RACE analyses as a guide. The 5Ј end of RNA2 is as described previously (Dasgupta and Sgro, 1989) .
b,c Template consisted of (b) vRNA from an NoV stock grown in G. mellonella larvae or (c) total cellular RNA from BHK21 cells transfected with this vRNA.
d The same sequence was found with both templates (b) and (c), in 5/5 and 4/4 clones, respectively. e 1/6 RNA1 clones had an extra C residue at the dimer junction. f Template RNA consisted of vRNA from an NoV stock grown in suckling mice. g 1/6 RNA2 clones had a large deletion at the dimer junction.
the 5Ј terminal sequence was 5ЈGUAUU. . .3Ј (Table 1 and Fig. 1, top panel) . The 5Ј end of subgenomic RNA3 was 5ЈGUGUA. . .3Ј (Fig. 1, middle panel) , which mapped the RNA3 start site to nt 2732 of RNA1 (Johnson et al., 2001a; Johnson et al., 2001b) . For RNA2, PE analysis ( Fig.  1 , bottom panel) confirmed the 5Ј terminal sequence of 5ЈGUAAA. . .3Ј (Dasgupta and Sgro, 1989) . Replication of the functional NoV cDNA clones in BSR T7/5 cells (see below) produced RNAs with authentic 5Ј ends; the corresponding PE products co-migrated with those detected after vRNA transfection (Fig. 1) . For each RNA, PE products 1 nt longer than the authentic 5Ј termini were also observed (Fig. 1) . Similar ϩ1 products are detected for FHV RNAs (Ball, 1995; Ball and Li, 1993) and likely represent reverse transcriptase extending onto their 5Ј cap structures, as previously described (Davison and Moss, 1989) . To determine directly whether the ϩ1 species did correspond to 5Ј caps, RNAs from BSR T7/5 cells transfected with both genomic clones were treated with tobacco acid pyrophosphatase (TAP) to remove cap structures and subjected to PE analysis. For RNA2, we observed a decreased amount of the ϩ1 product upon TAP treatment, and a concomitant increase in the amount of the expected product (Fig. 1 , Lanes 6 and 7), confirming that NoV RNA2 was capped, consistent with an earlier report (Kaesberg et al., 1990 ).
The TAP treatment had a less profound effect on RNAs 1 and 3 (data not shown), perhaps because of the lower abundance of the RNA1 and RNA3 species at the ϩ1 position (Fig. 1) . Nevertheless, we interpret these ϩ1 RNA species as RNA1 and RNA3 with 5Ј caps as shown for NoV RNA2.
The 3Ј terminal sequences of both genomic RNAs were determined by reverse transcription polymerase chain reaction (RT-PCR) on RNA homodimers, rather than by conventional methods, because the 3Ј ends of singlestranded nodavirus RNAs are blocked to chemical and enzymatic modification (Dasmahapatra et al., 1985; Guarino et al., 1984; Kaesberg et al., 1990) . Again using total cellular RNA from vRNA-transfected BHK21 cells as a template, we amplified 3Ј-5Ј junctions of negative strand copies of head-to-tail dimers of RNA1 and RNA2 that arise naturally during RNA replication (Albariño et al., 2001; and determined the sequences of 6 independent junction clones for each (Table 1). For clarity of presentation in Table 1 , these sequences have been separated into their corresponding 5Ј and 3Ј termini using the 5Ј terminal sequences determined above (Table 1 and Fig. 1 ). For RNA1, the consensus 3Ј terminal sequence was 5Ј. . .GUGGU3Ј. RT-PCR across dimer junctions also allowed us to complete the 3Ј terminal sequence of NoV RNA2. Originally reported FIG. 1. Mapping of the 5Ј termini of NoV genomic and subgenomic RNAs. BSR T7/5 cells, which constitutively express T7 RNA polymerase (Buchholz et al., 1999) , were transfected with NoV vRNA or with functional clones of NoV RNA1 and RNA2, either alone or in combination. Total cellular RNAs were isolated and analyzed by PE, using primers specific for NoV RNA1 (top), RNA3 (middle), or RNA2 (bottom). PE products were separated on a 5%-polyacrylamide sequencing gel along with sequencing ladders generated with the same primers and plasmid DNA templates. The NoV genome organization is shown schematically at left. Left panels: Transfection with vRNA (Lane 1), pNoV1(0,0) alone (Lane 2) or together with pNoV2(0,0) (Lane 3), pNoV2(0,0) alone (Lane 4), or mock transfection (Lane 5). Right panel: Transfection with pNoV1(0,0) and pNoV2(0,0) as above. Total cellular RNAs were treated with TAP to remove 5Ј cap structures (Lane 6), or mock treated (Lane 7) prior to PE using the RNA2 primer. as 5Ј. . .UUGX3Ј (Dasgupta and Sgro, 1989) , we found the complete sequence to be 5Ј. . .UUGGU3Ј (Table 1) .
Full-length cDNAs of NoV RNA1 and RNA2 were synthesized by RT-PCR, using primers whose sequences were derived from the consensus termini shown in Table  1 , and ligated into transcription plasmid TVT7R(0,0) . The resulting plasmids, pNoV1(0,0) and pNoV2(0,0), contained the general sequence arrangement 5Ј-T7 promoter-NoV cDNA-HDV ribozyme cDNA-T7 terminator-3Ј. The 5Ј ends of the primary T7 transcripts are defined by promoter positioning and their 3Ј ends by ribozyme cleavage (Ball, 1994) . The (0,0) nomenclature follows our previous convention, where the numbers in parentheses represent the number of extraneous nucleotides at the 5Ј and 3Ј termini, respectively, of the final ribozyme-cleaved transcript (Ball and Li, 1993) . Unlike cDNA clones of FHV and PaV RNA1 (Ball, 1995; Johnson and Ball, 2001 ), pNoV1(0,0) required no extraneous nucleotides between the T7 promoter and the first nucleotide of the NoV RNA1 cDNA to direct efficient primary T7 transcription and subsequent RNA replication in BSR T7/5 cells.
The cDNA inserts of these clones were sequenced. Detailed analysis of the NoV RNA1 cDNA sequence and its comparison to the RNA1 sequences of five other nodaviruses has been published elsewhere (Johnson et al., 2001a) . NoV RNA1 is 3204 nt in length and the organization of its open reading frames (ORFs) is typical of the Nodaviridae.
RNA2 is 1336 nt in length and encodes protein ␣, the capsid protein precursor (Dasgupta and Sgro, 1989) . In addition to the GU dinucleotide at the 3Ј end (Table 1 , see above), the sequence of the NoV RNA2 cDNA clone differs from the published RNA2 sequence (Accession number X15961; Dasgupta and Sgro, 1989) at the following positions, with the effects on the protein ␣ coding region shown in parentheses: G328U (silent), C854G and G855C (Arg279Ala), A1196G (Thr393Ala), C1292U (3Ј UTR). The mass of protein ␥ as determined by MALDI-TOF MS is consistent with an alanine at position 393 in our preparation of the NoV Mag115 field isolate .
RNA replication in mammalian cells expressing T7 RNA polymerase
Our laboratory has previously developed technology for the in vivo production of replication-competent primary T7 transcripts of FHV and PaV genomic RNAs (Albariño et al., 2001; Johnson and Ball, 2001 ). This system relies on transfection of DNA plasmids into BSR T7/5 cells, which express T7 RNA polymerase (Buchholz et al., 1999) . Plasmids pNoV1(0,0) and pNoV2(0,0) were transfected alone or together into BSR T7/5 cells. At 48 h post-transfection, the products of the viral RdRp were labeled for 3 h with [
3 H]uridine in the presence of actinomycin D as described in Materials and Methods and separated on a denaturing agarose gel (Fig. 2) . On transfection of pNoV1(0,0) alone we detected an RNA replication product (Fig. 2 , Lane 3) that co-migrated with authentic RNA1 produced on transfection with vRNA ( Fig. 2 , Lane 1). We also detected synthesis of subgenomic RNA3, another indicator of nodavirus RNA replication. On co-transfection of both genomic clones, RNA2 was replicated and RNA3 production was down regulated (Fig. 2, Lane 7) , as expected from a previous report (Ball et al., 1992) . We also observed RNA2-mediated suppression of RNA3 synthesis by PE analysis (Fig. 1 , middle panel, compare Lanes 1 and 2). Suppression of NoV RNA3 was consistently less severe than that seen with FHV, such that a residual level of RNA3 was observed even in the presence of RNA2 replication ( Fig. 2 and data not shown). The RNA2 derived from the cDNA clone co-migrated with authentic NoV RNA2 produced on vRNA-transfection (Fig. 2 , compare Lanes 1 and 7). When pNoV2(0,0) was transfected alone, no RNA replication was observed (Fig. 2 , Lane 6) and we detected no primary RNA2 T7 transcripts by PE (Fig. 1, bottom panel, Lane 4), attesting to the low abundance of RNA2 in the absence of RNA replication. The recombinant RNAs replicated with similar efficiencies at 28°C, 31°C, and 34°C (data not shown). They also replicated at 37°C at a greatly reduced rate, as previously described for NoV vRNA (Ball et al., 1992) .
During construction of the NoV RNA1 cDNA clone, we discovered a mutant cDNA that produced less RNA3 than did the wild-type. Sequence analysis showed that the mutant clone differed from pNoV1(0,0) at 13 nucleotide positions. After introduction of these changes into the wild-type sequence, we observed that the single mutation U1274C reduced the RNA3:RNA1 ratio by 80% relative to wild-type (Fig. 2 , Lane 4). This mutation encoded a valine to alanine change at position 418 of the RdRp. To determine whether the observed phenotype was caused by this amino acid change, we separated the RNA1 template and RdRp mRNA functions onto two different RNAs expressed from separate T7 transcription plasmids, as described for FHV (Ball, 1994; Eckerle and Ball, 2002) . The results indicated that a defect in the RNA template, rather than in the RdRp, was responsible for the phenotype (data not shown). The mutation at 1274 is 1458 nt upstream of the start site of RNA3, suggesting the possibility of a long-range interaction between the two regions . This suggestion is consistent with the observation that a similar region in FHV RNA1 forms a base-pairing interaction with a region just upstream of the RNA3 start site, and that this interaction enhances RNA3 synthesis (Lindenbach et al., 2002) .
Since the ability of FHV RNA2 to replicate is absolutely dependent upon the presence of FHV RNA3 (Eckerle and Ball, 2002) , we compared the ability of the U1274C mutant to support RNA2 replication with that of the wild-type RNA1. The mutant RNA1 clone was also defective in its ability to support replication of RNA2 in trans, synthesizing 70% less RNA2 than the wild-type RNA1 clone (Fig. 2 , compare Lanes 7 and 8). These data suggest that the RNA3-dependent control mechanism proposed for coordination of the replication of FHV genome segments may extend to other alphanodaviruses.
Synthesis of small nonstructural proteins encoded by NoV RNA3
Li et al. (2002) have recently shown that FHV B2 suppresses RNA silencing/interference, establishing for the first time a possible function for this small nonstructural protein. For this reason, we examined the translation products of NoV RNA3 in some detail. The sequence of NoV RNA3 reveals two overlapping ORFs (Johnson et al., 2001a) . That closest to the 5Ј end of RNA3 overlaps the protein A ORF in the ϩ1 reading frame and is predicted to direct a primary translation product that contains 137 aa residues. However, the fourth codon in this ORF is another AUG, and initiation here would yield a 134-residue protein (Fig. 3A) . The second ORF initiates at the third AUG codon in RNA3 and represents the C-terminal 131 aa residues of protein A (Fig. 3A) . By analogy with the RNA3 ORFs in BBV, FHV, and PaV, we designated these ORFs B2 and B1, respectively. To identify their translation products, we mutated their initiation codons, either singly or in combination (Fig. 3A) , and examined the small nonstructural proteins that accumulated in plasmidtransfected cells using SDS-PAGE, MALDI-TOF MS, and peptide mapping of wild-type and mutant products.
An abundant viral protein with an M r of about 15 kDa accumulated in BSR T7/5 cells transfected with wild-type pNoV1(0,0) (Fig. 3B , Lane 2), and to a lesser extent in cells transfected with pNoV1(0,0)U1274C (Fig. 3B , Lane 3). On excision of the wild-type protein band from an SDS-PAGE gel, MALDI-TOF MS analysis showed that it contained two species. Subsequent MALDI-TOF analysis of a wild-type-transfected cell lysate confirmed the presence of two species (molecular masses 14595 and 14942 Da) that differed by 347 Da in mass (Fig. 4A) ; both species were also detected in the U1274C-transfected lysate (data not shown). The larger was eliminated by mutation of the first AUG codon in RNA3 (mutant 4; ). Furthermore, the individual 15-kDa proteins produced by mutants 2 and 4 both yielded B2-specific tryptic peptides, which identified them as the products of translation of the B2 ORF, although their distinctive N-terminal peptides were not detected (data not shown). Accordingly, we refer to these proteins as B2-137 and B2-134.
A new protein with an apparent M r of 20 kDa accumulated in cells transfected with the mutant 1 version of pNoV1(0,0) (Fig. 3B , Lane 4). Upon excision from the gel, trypsin digestion, and MALDI-TOF MS analysis, the NoV protein yielded the B1-specific tryptic peptides shown in Table 2 . Gel purification of the protein before digestion allowed us to distinguish B1-derived peptides from those derived from the 116-kDa protein A.
Genetic analyses confirmed the identification of the 20-kDa protein as the translation product of the B1 ORF. In mutants 3-5, the AUG at the start of the B1 ORF was changed to CUG (Fig. 3A) . Despite the unavoidable introduction of a M913L mutation in protein A, these mutants exhibited wild-type rates of RNA replication when assayed by metabolic labeling (data not shown), showing that this mutation had no major effect on RdRp activity. However, elimination of the B1 AUG rendered the 20-kDa species undetectable by SDS-PAGE (Fig. 3B , Lanes 6-8) and by MALDI-TOF MS and tryptic peptide analyses (Table 2) . Proteins B2-137, B2-134, and B1 were not made during replication of mutant 5, in which both B2 and B1 ORFs were eliminated (Fig. 3B, Lane 8) .
Compared to the wild-type, protein B1 accumulated to excess during replication of mutants 1 and 2 (Fig. 3B , Lanes 4 and 5), presumably as a result of the altered sequence context of the B1 AUG. However, lower levels of B1-specific peptides were detected in cells transfected with the wild-type NoV1 cDNA when the corresponding 20-kDa region was excised from an SDS-PAGE gel, digested with trypsin and analyzed by MALDI-TOF MS (Table 2 ). This observation indicates that some B1 was synthesized during replication of the wild-type RNA1.
Mutations that disrupt the FHV B2 ORF have little effect on RNA replication in BHK21 cells or in yeast (Ball, 1995; Price et al., 2000) , although similar mutations reduce or inhibit FHV replication in Drosophila cells (Harper, 1994; Li et al., 2002) . We tested the effect of NoV mutant 1 on RNA replication in BSR T7/5 cells and observed no difference in the rates of RNA1 replication or RNA3 synthesis, nor any effect on the ability to replicate RNA2 in trans (Fig. 2 , compare Lanes 5 and 9). Similar results were observed for mutants 2-5 (data not shown), suggesting that RNA replication in BSR T7/5 cells did not require synthesis of proteins B2 or B1.
In summary, we conclude from these genetic and biochemical analyses that the NoV B2 ORF yields abundant proteins from both its first and second AUG codons (B2-137 and B2-134 respectively). In addition to these species, lower levels of protein B1 were detected during wild-type NoV RNA1 replication. Previous to this work, B1 protein synthesis was confirmed only for FHV (Harper, 1994) , where the B1 ORF initiates before that of B2 (Guarino et al., 1984) . The functions of NoV B1 and B2 proteins remain to be determined.
Capsid protein synthesis
We examined synthesis of protein ␣, the viral capsid protein precursor, in transfected cells labeled with [
35 S]methionine and [ 35 S]cysteine using SDS-PAGE (Fig.  5) and Western blot analyses (data not shown). As a control, we analyzed the protein content of non-recombinant NoV (Mag115) virions. We detected protein ␣ (43 kDa) and the larger of the mature capsid proteins, ␤ (38 kDa), by Coomassie staining and by autoradiography of . Both proteins were immunoreactive with rabbit hyperimmune serum raised against purified NoV (Gallagher, 1987) . The smaller cleavage product, protein ␥ (4.6 kDa), was not labeled because it contains no methionine or cysteine residues (Dasgupta and Sgro, 1989; but a protein of the appropriate size was detected by Western blot (data not shown).
In cells transfected with pNoV2(0,0) together with wildtype, U1274C or mutant 1 pNoV1(0,0) plasmids, we detected a protein that co-migrated with ␣, at levels that appeared similar by SDS-PAGE regardless of the genotype of the NoV1 species (Fig. 5 , Lanes 6-8). Protein ␣ was not seen in mock-transfected cells (Fig. 5 , Lane 1) or in cells transfected with any of these pNoV1(0,0) plasmids alone (Fig. 5 , Lanes 2-4) or with pNoV2(0,0) alone (Fig. 5 , Lane 5), consistent with the low abundance of the NoV RNA2 primary transcript (Fig. 1) . Relatively little protein ␤ was detected in transfected cell lysates by Western blot, compared to ␣, yet ␤ was readily detected in purified virions. We attribute the scarcity of ␤ in freshly prepared cell lysates to the slow cleavage of ␣ into ␤ ϩ ␥ which occurs predominantly during and after virus purification (Zlotnick et al., 1994) . However, the detection of protein ␥ by Western blot in cells co-transfected with pNoV2(0,0) and either wild-type or mutant U1274C versions of pNoV1(0,0) (data not shown) suggested that at least some capsid protein cleavage occurred.
Recovery of infectious virus from NoV cDNA clones
We tested for the presence of infectious recombinant NoV in transfected BSR T7/5 cell lysates by injecting them into larvae of the greater wax moth, G. mellonella. NoV infection in G. mellonella larvae causes paralysis of the hind-most segments, progressing to death within 7-14 days (Bailey et al., 1975; Garzon et al., 1990) . These larvae have been used as a test for infectivity of NoV grown in a variety of host cells and animals and are more sensitive to NoV infection than suckling mice (Bailey et al., 1975) .
Lysates from cells transfected with pNoV1(0,0) alone, pNoV1(0,0) and pNoV2(0,0) together, or authentic vRNA, were injected into larvae. Those that died or became paralyzed within two days of the injection were likely injured during injection and thus were removed from the experiments. The remaining larvae (n) were scored for mobility and size on Day 11. The larvae were separated into three groups: healthy, paralyzed, or dead, according to the criteria outlined in the footnote to Table 3 . At no point during the incubation were sick or paralyzed larvae observed to recover either normal mobility or a normal growth phenotype.
Larvae injected with lysates from cells transfected with plasmids pNoV1(0,0) and pNoV2(0,0) together exhibited paralysis of the hind-most segments that progressed during the course of the experiments. By Day 11, none of the larvae remained healthy, 8 of 21 were paralyzed, and the rest were dead (Table 3) . Similar results were obtained with lysates from vRNA-transfected cells: 7 of 19 were paralyzed and 12 were dead (Table 3) . A similar pattern of infection was also observed when a, 15073; b, 15044; c, 14806; d, 14902. larvae were injected with purified mouse-derived NoV (data not shown). Most of the larvae injected with lysates from mock transfected cells (28 of 30) remained healthy over the course of the experiment, although two died from unknown causes. When larvae were injected with lysates from cells transfected with pNoV1(0,0) alone (Table 3) or, in a single experiment, pNoV2(0,0) alone (data not shown), the results were similar to those obtained with mock-transfected lysates. Pre-treatment of the pNoV1 ϩ pNoV2 lysate with RNaseA had no effect, showing that the infectivity was due to infectious virus rather than infectious RNA (data not shown); this experiment was performed once in infected larvae, but was repeated several times in BHK21 cells with identical results (see below). We concluded that the NoV cDNA clones directed the assembly of viral particles that were infectious for G. mellonella larvae.
Infectivity of NoV for BHK21 cells and time course of RNA replication
NoV was reported to be infectious for BHK21 cells, but the literature suggests that these results were not consistently reproducible (Bailey et al., 1975; Ball et al., 1992; Garzon et al., 1978; Hiscox and Ball, 1997; Newman and Brown, 1977; Newman et al., 1978) . The NoV cDNA clones allowed us to reexamine the issue of BHK21 cell infectivity using the more sensitive technique of Northern blot hybridization. We found that authentic, mouse-derived NoV and recombinant NoV derived from the cDNA clones were both infectious for BHK21 (Fig. 6 ) and BSR T7/5 cells (data not shown), confirming the infectivity of the cloned cDNAs. NoV infectivity in BHK21 cells was resistant to treatment with RNaseA and could be neutralized with a rabbit hyperimmune serum raised against purified, mouse-derived NoV (data not shown).
The infectivity of NoV for BHK21 cells allowed us to examine the accumulation of viral RNAs in NoV-infected cells over a 12-day time course. Cells were infected with 1000 particles per cell of authentic NoV isolated from infected suckling mice (Figs. 6A and 6B ) or of recombinant NoV grown in G. mellonella larvae (Figs. 6C and 6D) , and incubated for 12 days at 28°C. Cells were harvested at 24 h intervals and total cellular RNAs were isolated and analyzed by Northern blot hybridization using probes specific for the positive (Figs. 6A and 6C) or negative (Figs. 6B and 6D) strands of NoV RNAs 1, 2 and 3. NoV a Lysates of transfected cells were injected into groups of 12 larvae. Larvae that died or became paralyzed within 2 days of injection were removed from the experiment. The remaining larvae (n) were scored for mobility and size on day 11: healthy larvae were mobile and increased in size over the incubation period, paralyzed larvae exhibited difficulty in locomotion and stunted growth, while the remaining larvae died.
b The results of three (mock transfection) or two experiments were pooled for this analysis. a Mock-, wildtype-or mutant pNoV1(0,0)-transfected BSR T7/5 cell lysates were separated on SDS-PAGE gels. The B1 region of each lane was excised and digested with trypsin. The resulting peptides were isolated; their masses were determined by MALDI-TOF MS and compared to those of the tryptic peptides predicted from the B1 sequence. Peptides with identical masses were detected for wildtype pNoV1(0,0), mutant 1 and mutant 2, while no B1-specific peptides were detected for mock lysates or lysates from cells transfected with mutants 3-5, which lack the B1 ORF. 
RNA from purified virions was included in the positivestrand gels as a marker (Lane 1).
No viral RNA was detected at the time of infection (Figs. 6A and 6C, Lane 2), or in mock-infected samples that were incubated for 10 days (data not shown), whereas we detected genomic RNA1 and RNA2 by 24 h post-infection (p.i.; Figs. 6A and 6C, Lane 3). At 24 h p.i., we also detected subgenomic RNA3, which is synthesized by the RdRp only during RNA replication, showing that the genomic RNAs were replicating. Accumulation of positive strand viral RNAs increased gradually over the next 11 days (Fig. 6A, Lanes 3-13 ). Similar accumulation of positive-strand RNAs was observed for the recombinant NoV stock, although with slightly delayed kinetics (Fig. 6C) . We also detected the accumulation of negative strand copies of RNAs 1, 2, and 3, confirming that RNA replication was occurring in these cells (Figs. 6B and  6D ). In addition, we observed homodimeric forms of NoV RNAs 1, 2 and 3 (Fig. 6 ) like those described for FHV RNAs (Albariño et al., 2001) ; homodimers of both polarities were detected, although they were more readily visible in the negative strand blots (Figs. 6B and 6D) . Quantitation of the Northern blots allowed us to examine the molar ratios of NoV RNA1 and RNA2 positive to negative strands, which were approximately 100:1, consistent with previous reports for FHV (Albariño et al., 2001) .
The continuous synthesis of RNA3 throughout the 12 day time course of infection was unexpected (Fig. 6) , since we observed the expected shutoff of RNA3 synthesis in the presence of RNA2 in BSR T7/5 cells transfected with vRNA or with plasmids (Fig. 2) . The shutoff was also observed on transfection of BHK21 cells with NoV vRNA (data not shown). The apparent discrepancy may be due to technical differences between the two experiments: in transfected cells we measured the rate of RNA3 synthesis by metabolic labeling (Fig. 2) , whereas in infected cells we analyzed the accumulation of RNA3 by Northern blot hybridization (Fig. 6 ). However, it is possible that there is an inherent difference in an infectious cycle initiated by infection from one initiated by transfection, even of RNA isolated from purified virions. Further work will be required to reconcile the two observations.
The susceptibility of BHK21 cells to NoV infection also allowed us to quantitate the yield of infectious NoV particles from transfected BSR T7/5 cells in the absence of a plaque assay. We determined the viral yields using an endpoint dilution assay in infected BHK21 cells, coupled with Northern blot analysis using a probe specific for the positive strands of RNAs 1, 2 and 3 (data not shown). BSR T7/5 cells were transfected with pNoV2(0,0) together with either wild-type pNoV1(0,0) or the U1274C mutant; 5 d after infection cell lysates were prepared, treated with RNaseA and used to infect BHK21 cells. Infection of parallel wells with known quantities of gradient-purified recombinant NoV isolated from G. mellonella larvae generated a standard curve. According to this assay, the yield of wild-type recombinant NoV from plasmid-transfected BSR T7/5 cells was estimated to be 2.5 ϫ 10 5 particles per cell. However, because the efficiency of plasmid DNA transfection into these cells was likely less than 100%, this figure is probably a significant underestimate.
Recombinant U1274C particles were also infectious for BHK21 cells, although the yield of infectivity was about 100-fold lower than that of wild-type particles, when measured by the same endpoint dilution assay. When analyzed by Northern blot at 5 d p.i., the ratio of RNA2 to FIG. 6 . Time course of NoV infection in BHK21 cells. Cells in parallel wells were infected with 1000 particles per cell of either authentic, mouse-derived NoV (panels A and B), or recombinant NoV isolated from G. mellonella larvae (panels C and D), or mock infected (data not shown), and incubated at 28°C for 12 days. Cells were harvested at 24 h intervals, starting at the time of infection. Total cellular RNAs were isolated, resolved by electrophoresis on agarose-formaldehyde gels, and detected by Northern blot analysis using probes specific for the positive-(panels A and C) or negative-(panels B and D) strands of NoV RNAs 1, 2, and 3. In each case exposure times were identical, but 5 times more RNA was loaded for the detection of negative strands than for positive strands. Lane 1 contains 5 ng of authentic NoV vRNA in the positive-strand blots and was left blank in the negative-strand blots.
RNA1 was reduced 70% compared to that of the wildtype, showing that this virus had retained its mutant phenotype in the infected cell (data not shown). We confirmed the presence of the U1274C mutation in infected cells by RT-PCR and sequencing of a 300 bp region of the bulk RT-PCR product spanning nt 1274 (data not shown).
DISCUSSION
The BSR T7/5 cell system reproduced many of the features of NoV RNA replication observed after transfection of NoV vRNA into BHK21 cells (Ball et al., 1992) . On transfection of pNoV1(0,0) we observed autonomous replication of RNA1 and synthesis of subgenomic RNA3. When pNoV1(0,0) and pNoV2(0,0) were co-transfected, both genomic RNAs replicated and RNA3 synthesis was down regulated by RNA2 (Fig. 2) , as previously described (Ball et al., 1992) . RNA replication was maintained at a high level for at least 6 days after transfection (data not shown). We detected synthesis of viral nonstructural (Fig.  3B ) and structural (Fig. 5) proteins and showed that progeny virus particles were lethal for G. mellonella larvae (Table 3 ) and infectious for BHK21 cells (Fig. 6) . No cytopathic effects were observed even at very late times in infection; similar results were reported previously for BHK21 cells infected with authentic NoV (Ajello, 1979; Bailey et al., 1975) .
Kinetics of RNA replication in infected or transfected mammalian cells
The susceptibility of BHK21 cells for NoV allowed us to examine RNA replication over a 12-day time course following infection with authentic, mouse-derived virus (Figs. 6A and 6B) or with recombinant NoV grown in G. mellonella larvae (Figs. 6C and 6D ). Previous analyses of NoV infection in BHK21 cells quantitated the resulting infectivity and did not examine RNA replication (Bailey et al., 1975) . For both authentic NoV and recombinant NoV, we first detected replication of genomic RNAs 1 and 2 and synthesis of subgenomic RNA3 at 24 h p.i., and these RNA species accumulated over the next 11 days (Figs. 6A and 6C ). Negative strand copies of the genomic RNAs were also detected at 24 h p.i., whereas the negative strand of RNA3 was first seen above the level of a background band that migrated slightly slower than RNA3 at about 3 d p.i. Accumulation of the negative strands of all three RNAs also increased over the entire time course of the experiment (Figs. 6B and 6D ). Homodimeric species of RNAs 1, 2, and 3 of both polarities were seen beginning at about Day 4 and accumulated with kinetics similar to those seen for the monomeric species (Fig. 6) . Similar molecules arise during replication of FHV and PaV RNA and represent perfect head-totail dimers of RNAs 1, 2, and 3 (Albariño et al., 2001; Johnson and Ball, 2001) . The function of these species is unknown.
These kinetics of RNA replication were observed following infection at an m.o.i. of 1000 particles per cell. Under these conditions most cells were likely infected, even assuming a high particle-to-PFU ratio like that reported for FHV (Schneemann et al., 1992) . Perhaps the protracted time course was due to the establishment of a persistent infection in these cells. Indeed, a previous report showed that mosquito Aedes aegypti and Ae. albopictus cells infected with NoV produce infectious virus 4-16 days p.i. and appear to become persistently infected (Bailey et al., 1975) .
Mouse-derived NoV appeared to replicate slightly more robustly than the recombinant virus, particularly early in the infection (Fig. 6 , compare panels A and B with panels C and D). It is possible that the slight differences in the accumulation of RNA replication products between these two virus stocks derives from differences in the hosts from which they were isolated. The authentic virus stock was prepared from the hind limbs of infected suckling mice, whereas the recombinant virus stock was prepared after injection of a transfected BSR T7/5 cell lysate into G. mellonella larvae. The difference could also be attributed to slight differences in the extraction methods used for these two sources of infected animal tissue, as described in Materials and Methods. These possibilities will be the subject of further examination.
The kinetics of RNA replication observed after transfection of NoV vRNA into BHK21 cells (Ball et al., 1992) , or cDNA plasmids into BSR T7/5 cells (data not shown), are quite different from those seen after NoV infection (Fig.  6) . In vRNA-transfected cells synthesis of RNA1 is first detected by metabolic labeling 3-5 h post-transfection and that of RNA2 slightly later; replication of both RNAs continues at a high rate until at least 23 h post-transfection. RNA3 synthesis was also detected by metabolic labeling, but only during the first 13 h after transfection (Ball et al., 1992) .
In contrast, RNA replication initiated from cloned cDNAs in BSR T7/5 cells was not detected by metabolic labeling at 24 h. RNA replication reached its peak rate at 48 h and continued at a high rate for at least 4 more days (data not shown). The faster kinetics observed after vRNA transfection, also seen for FHV and PaV (Albariño et al., 2001; Johnson and Ball, 2001) , may be attributed to the delivery of capped, functional RNAs directly to the cytoplasm where translation and RNA replication occurs. Delivery of plasmid DNA to BSR T7/5 cells requires the additional step of primary T7 transcription, which generates uncapped RNAs that are likely to be poor templates for translation, before the RNAs can be amplified.
In infected cells, the gradual onset of RNA replication may be due to infection of a non-native type of host cell (i.e., BHK21 cells); this block is circumvented when the infectious cycle is initiated by transfection. BSR T7/5 cells, together with the BHK21 cells from which they were derived (Buchholz et al., 1999) , will allow us to study all of these processes, from initiation of primary transcription from cDNA clones through particle production to a second round of infection, in a single cell type.
Coupling between RNA3 synthesis and RNA2 replication
A mutant RNA1 with a U to C substitution at position 1274 directed synthesis of only 20% as much RNA3 as did the wild-type NoV1 clone (Fig. 2) . This mutant also supported RNA2 replication at 30% of the wild-type level (Fig.  2) , showing that there is a linkage between RNA3 synthesis and RNA2 replication for NoV as described for FHV (Eckerle and Ball, 2002) . On co-transfection of BSR T7/5 cells with the U1274C mutant and pNoV2(0,0) the protein ␣ capsid precursor was synthesized (Fig. 5) and infectious virus was produced, although the yield of infectivity was about 100-fold lower than that obtained with the wild-type RNA1 clone. We speculate that this reduction in infectivity is related to the shortage of RNA2 rather than of protein ␣, but this remains to be determined.
The mechanism of RNA3 synthesis has not yet been defined for any of the alphanodaviruses. However, sequences in FHV RNA1 that modulate RNA3 synthesis include a region that spans the RNA3 start site (nt 2721 for FHV) by at least 10 nt upstream and several nt downstream and a second region nearly 100 nt upstream of the RNA3 start site (Eckerle and Ball, 2002) . It remains to be determined whether the analogous positions in NoV RNA1 will prove important for synthesis of its RNA3. However, the results presented here (Fig. 3A) suggest a role for a third region that encompasses nt 1274 in the synthesis of NoV RNA3, despite its position 1458 nt upstream of the RNA3 start site at nt 2732. This effect suggests potential long-range interactions between this region and sequences near the start of RNA3 . This suggestion is consistent with the report that an analogous region in FHV forms a basepaired interaction with a region immediately upstream of the start of RNA3 that enhances RNA3 synthesis (Lindenbach et al., 2002) . The computer-predicted secondary structure described for the positive strand of FHV RNA1, in which nt 1227-1232 pairs with complementary nt 2716-2711 (helix 1) and nt 1234-1239 pairs with nt 2520-2515 (helix 2), is also predicted to form for the analogous regions of the positive strand of NoV RNA1 (Lindenbach et al., 2002) . NoV nt 1274 lies just outside of the predicted secondary structure.
Identification of small nonstructural proteins encoded by NoV RNA3
The relationship between the B2 and B1 protein ORFs encoded by NoV RNA3 and synthesis of these small nonstructural proteins was deciphered using a combination of genetic analysis and MALDI-TOF MS (Figs. 3 and  4) . We showed that two forms of protein B2 are synthesized, although the 134 aa form appears by SDS-PAGE analysis to be predominant, at least in transfected BSR T7/5 cells (Fig. 3B) . Because B2-137 and B2-134 differ by only 3 aa we assume that their stabilities are similar. Their second residues (T and S, respectively) are both stabilizing according to the N-end rules for protein stability (Varshavshy, 1996) .
The molecular masses we obtained for proteins B2-137 and B2-134 by mass spectrometry (14942 Da and 14595 Da, respectively; Figs. 4A and 4D) differed from one another by 347 Da, within 1 Da of the interval predicted by the 3 aa difference between the two (MTN; 346 Da). Similarly, we obtained masses for the wild-type (14942 Da) and mutant 2 (14912 Da) versions of B2-137 that differed by exactly the interval of 30 Da predicted by the M to T mutation at position 4 (Figs. 3A, 4A and 4C ). This concordance gave us great confidence in the relative mass measurements we obtained, but the values relative to the standard, apomyoglobin, were consistently 91-92 Da lower than predicted for both B2-137 (predicted mass 15033) and B2-134 (predicted mass 14687). These differences are likely due to post-translational modifications such as removal of the N-terminal methionine residue and the addition of one or more small modifying groups. A previous report that only 1-5% of purified FHV B2 protein was accessible to N-terminal sequencing is consistent with the presence of an undefined modifying group at its N-terminus (Harper, 1994) .
The abundance of B2-134 in transfected cells was somewhat surprising, since the B2-134 ORF initiated at the second AUG codon in RNA3 (Fig. 3A) , while the ribosome-scanning model of translation initiation would favor the first AUG codon (Kozak, 1999) . These AUG codons had equivalent flanking consensus translation initiation sequences (Cavener and Ray, 1991; Kozak, 1999) . It is possible that its position only 13 nt from the 5Ј end of RNA3 prevents the efficient recognition of the B2-137 AUG (Kozak, 1991) . However, we detected B2-137 protein even in the wild-type case (Fig. 4A ) and in the absence of the B2-134 AUG, the B2-137 protein was up regulated (Fig. 3B , Lanes 2 and 5), suggesting that the proximity of the B2-137 AUG to the 5Ј end may not be inhibitory. Perhaps there is a specific mechanism to regulate the balance between the two forms of NoV B2. This possibility remains to be investigated.
In view of the abundant synthesis of B2-137 and B2-134 from the first two AUG codons in RNA3, translation of the B1 ORF was unexpected, yet we detected low levels of B1 protein even in wild-type-transfected cells. The B1 initiation codon is the third AUG in RNA3 and its sequence context for translation initiation is similar to those of the B2 ORFs; only 2 nt separates the B1 AUG from that of B2-134 (Fig. 3A) . The observation that B1 was expressed more efficiently when the B2-134 AUG was changed to ACG (threonine) (Fig. 3A and Fig. 3B , Lanes 4 and 5) suggests that perhaps the B1 AUG is used inefficiently due to its occlusion by the B2-134 AUG. Nonetheless B1 was detected in wild-type-transfected cell lysates.
Synthesis of nodavirus B1 protein has been confirmed experimentally for only FHV (Harper, 1994) . The B1 ORF is the 5Ј proximal ORF on FHV RNA3, yet only low amounts of this protein are made in FHV-infected Drosophila cells, perhaps because the translational initiation context is sub-optimal and the AUG that initiates B1 is only 8 nt from the 5Ј end (Harper, 1994) . Like NoV B1, FHV B1 (102 aa) migrates aberrantly in SDS-PAGE gels relative to the larger B2 protein (106 aa). NoV B1 shares only 34% sequence identity with FHV B1 (data not shown), but both are C-terminal fragments of protein A and both have unusually high isoelectric points (12.59 for NoV and 12.58 for FHV; data not shown) which may account for their anomalous mobilities in SDS-PAGE gels.
The functions of NoV B1 and B2 proteins remain unknown. No role for B1 has been proposed for any of the nodaviruses examined to date, and BoV and SJNNV lack this ORF entirely (Harper, 1994; Iwamoto et al., 2001) . NoV B2 mutant 1, which lacked both B2 ORFs, exhibited wild-type rates of RNA replication in BSR T7/5 cells. We observed no difference in the rates of RNA1 replication or RNA3 synthesis, nor any effect on the ability to replicate RNA2 in trans (Fig. 2 , Lanes 5 and 9). Similar results were observed for mutants that removed the B1 ORF, either singly or together with one or both B2 ORFs (data not shown), suggesting that RNA replication in BSR T7/5 cells did not require synthesis of proteins B2 or B1. Similarly, the FHV B1 and B2 proteins are dispensable for RNA replication in mammalian and yeast cells (Ball, 1995; Eckerle and Ball, 2002; Price et al., 2000) , as is PaV B2 dispensable in mammalian cells (Johnson and Ball, 2001) . FHV mutants lacking the B1 ORF replicate in Drosophila cells and produce wild-type levels of infectious virus (Harper, 1994) . In contrast, FHV B2 is necessary for wild-type levels of viral replication in Drosophila cells (Harper, 1994; Li et al., 2002) .
FHV B2 has recently been implicated as a suppressor of RNA silencing/interference in Drosophila cells and in plants (Li et al., 2002) . The possibility that NoV B2 may share the RNA silencing suppressor function will be considered elsewhere.
Summary
In summary, we have reproduced the infectious cycle of NoV from cDNA clones expressed in mammalian cells. The tools we describe here will facilitate the study of NoV RNA replication and pathogenesis, and the development of nodavirus-based expression systems.
MATERIALS AND METHODS
Cells and viruses
Baby hamster kidney BHK21 cells were grown at 37°C as described (Ball et al., 1992) , except that the growth medium used was DMEM supplemented with 5% each newborn calf serum and fetal bovine serum (FBS). BSR T7/5 cells (Buchholz et al., 1999) were grown at 37°C in the same medium, supplemented in alternate passages with 600 g/ml G-418 (Gibco Invitrogen Corporation), as described previously (Albariño et al., 2001) .
NoV, obtained from the American Type Culture Collection (ATCC; VR-679, strain Mag115), was propagated in infected suckling mice and purified from the back and hind limb musculature as described (Ball et al., 1992; Newman and Brown, 1973) . Alternatively, NoV was propagated in G. mellonella larvae injected with the mousederived virus (Bailey et al., 1975) and gradient-purified as described for PaV . Recombinant NoV particles derived from the cDNA clones were isolated from G. mellonella larvae infected with a lysate from transfected BSR T7/5 cells as described below. Particle concentration was calculated using an extinction coefficient at a wavelength of 260 nm of 4.15/mg (Longworth and Carey, 1976) and particle mass of 8 ϫ 10 6 g/mol (Newman and Brown, 1977) .
Terminal sequence determination and cDNA synthesis
Virion RNAs (vRNAs) were extracted from purified NoV particles as described (Ball et al., 1992; Chomczynski and Sacchi, 1987) . Genomic RNA was used as a template for first strand cDNA synthesis by Superscript II reverse transcriptase (Invitrogen Life Technologies) using random hexameric primers. NoV1-specific primers were designed from the sequences of partial NoV RNA1 cDNA clones and used to generate larger cDNAs. 5Ј terminal RNA1 cDNA clones were generated by 5Ј-RACE using as a template total cellular RNA from vRNA-transfected BHK21 cells. The same template was used to generate junction clones of RNA1 and RNA2 by RT-PCR across 3Ј-5Ј dimer junctions, as described in Results. Full-length RT-PCR products were inserted into a plasmid vector and 6 independent clones of each were sequenced.
Full-length cDNAs of NoV RNA1 and RNA2 were synthesized by RT-PCR using genomic RNA templates and primers specific for the termini of each, and ligated into plasmid TVT7R(0,0) . The cDNA inserts of the resulting plasmids, pNoV1(0,0) and pNoV2(0,0), were sequenced completely along both strands. These sequences were deposited with GenBank (Accession numbers AF174533 and AF174534 for NoV1 and NoV2, respectively).
Site-directed mutagenesis
The indicated NoV RNA1 mutations were generated by PCR-based circular mutagenesis followed by DpnI selection, as described (Sambrook and Russell, 2001 ). In each case, plasmid pNoV1(0,0) was amplified using PfuTurbo DNA polymerase (Stratagene) and the mutagenic oligonucleotides detailed below. The regions of interest were confirmed by sequencing, and small DNA fragments carrying the desired mutations were re-ligated into the parental plasmid background using standard techniques (Sambrook and Russell, 2001) .
For U1274C, the mutagenic oligonucleotides were identical to NoV1 nt 1263-1292 and complementary to nt 1285-1251, respectively, except for the indicated change. Mutations affecting the B2 and/or B1 ORFs (mutants 1-5) were created using the following mutagenic oligonucleotides, which contain the mutations shown in Fig. 4A 
Transfection of mammalian cells
Confluent monolayers containing 2 ϫ 10 6 BHK21 or BSR T7/5 cells (per 10 cm 2 well) were transfected with 50 ng of purified vRNAs using LipofectAmine or LipofectAmine 2000 (Invitrogen Life Technologies) as described (Albariño et al., 2001) . Transfection of plasmid DNA (2.5 g pNoV1(0,0) or 1 g pNoV2(0,0), either alone or in combination) into confluent monolayers of BSR T7/5 cells was performed using LipofectAmine 2000, as above. Incubations were performed at 28°C for 24h (vRNA transfections) or 48 h (plasmid transfections) prior to metabolic labeling as below.
RNA labeling, isolation, and analysis
For transfected cells, the products of RNA replication were labeled by metabolic incorporation of [ 3 H]uridine in the presence of 20 g/ml actinomycin D as described (Ball et al., 1992) , except that labeling was for 3 h (beginning at 48 h post-transfection for plasmid-transfected cells and at 24 h for vRNA-transfected cells); under these conditions, only the products of RNA-dependent RNA synthesis are labeled. Samples to be analyzed by Northern blot hybridization were left unlabeled. In both cases, total cellular RNAs were isolated (Chomczynski and Sacchi, 1987 ) and analyzed as follows.
PE analysis. RNA samples (corresponding to 13% of a 10 cm 2 well) were either left untreated or treated with tobacco acid pyrophosphatase (TAP; Epicentre Technologies, Madison, WI) to remove 5Ј caps and analyzed by PE. PE products were resolved on 5% polyacrylamide sequencing gels alongside dideoxynucleotide sequencing ladders generated using the same primers on pNoV1(0,0) or pNoV2(0,0) plasmid templates, and visualized by autoradiography as described (Ball, 1995) . Oligonucleotide primers complementary to NoV RNA1 (nt 108-83), RNA2 (nt 102-81), or RNA3 (nt 2837-2812 of RNA1) were used.
Gel analysis. RNA samples (corresponding to 8% of a 10 cm 2 well for plasmid transfections or 4% of a well for vRNA transfections) were separated on denaturing formaldehyde-agarose gels and labeled RNAs were visualized by fluorography using pre-flashed x-ray film, as described (Ball et al., 1992; Laskey and Mills, 1975) . The relative amounts of the RNA replication products were quantitated by densitometric scanning of the resulting fluorographs.
Northern blot analysis. RNA samples (corresponding to 3.3% of a 10 cm 2 well for detection of (ϩ) strands and 16.5% of a 10 cm 2 well for detection of (Ϫ) strands) were resolved by electrophoresis on denaturing formaldehyde-agarose gels, transferred to Nytran nylon membranes (Schleicher and Schuell), and subjected to Northern hybridization as described previously (Price et al., 2000) . Strand-specific [ 32 P]-labeled RNA probes for NoV were generated by in vitro transcription from PCR products containing promoters of bacteriophage-encoded RNA polymerases (SP6 and T7) as described (Sambrook and Russell, 2001) . Probes for NoV RNA1 and RNA3 contained nt 2732-3204 of the appropriate sense NoV RNA1. Probes for NoV RNA2 contained nt 1-22 and 1100-1336 of the appropriate sense NoV RNA2. The results were visualized with a Molecular Dynamics PhosphorImager digital radioactivity imaging system. RNA replication products were quantitated from the resulting scanned images using ImageQuant software (Amersham Biosciences Products); only samples falling within the linear range of the assays were included. For the determination of positive-to-negative strand ratios, the levels of RNA accumulation from four independent time course experiments were averaged over days 4-10. Similar methods were used to quantitate the endpoint dilution assays.
Protein analysis
Transfected cells were labeled for 3 h (beginning at 48 h post-transfection for plasmid-transfected cells and at 24 h for vRNA-transfected cells); by metabolic incorporation of [
35 S]methionine and [ 35 S]cysteine and lysed in a solution containing 1% NP-40 and 0.4% deoxycholate as described previously (Ball et al., 1992) . Nuclei were removed by centrifugation, and proteins were analyzed described below.
[ 35 S]-labeled NoV virions were prepared by transfection of 2 ϫ 10 7 BSR T7/5 cells with non-recombinant NoV (Mag115) vRNA and metabolic labeling as above. The cells were lysed by addition of NP-40 to the medium, cellular debris was removed by centrifugation, and particles were pelleted through a 30% sucrose cushion as described .
Gel analysis. Samples corresponding to 4% of a 10 cm 2 well were separated on 12.5% polyacrylamide-SDS gels (Laemmli, 1970) and proteins were visualized by staining with Coomassie brilliant blue (Sigma) or by autoradiography. Background cellular proteins were found to transfer relatively more efficiently to PVDF membranes than did viral capsid proteins. Therefore autoradiography was used to visualize labeled NoV proteins remaining in the gel after the transfer.
Matrix-assisted laser desorption/ionization-time-offlight (MALDI-TOF) mass spectrometry.
Cell lysates were concentrated eightfold on Microcon columns with a 3K MW cutoff (Amicon Bioseparations), and samples corresponding to 4% of a 10 cm 2 well were diluted 1:10 with matrix and 1 l was pipetted onto a smooth plate. Sinapinic acid (Aldrich) dissolved in acetonitrile:0.1% TFA (1:1) was used as the matrix. Samples were analyzed in the positive mode on a Voyager Elite mass spectrometer with delayed extraction technology (PerSeptive Biosystems, Framingham, MA). The mass spectrometer was calibrated with apomyoglobin, which has a molecular mass of 16952 Da.
Alternatively, proteins from 6% of a 10 cm 2 well were separated on 12.5% polyacrylamide-SDS gels as above, stained with colloidal Coomassie (GelCode Blue; Pierce), and the B2 and B1 regions were individually excised from the gels. The samples were destained by washing with acetonitrile:25 mM ammonium bicarbonate (1:1) and dried. The gel-slices were subjected to in-gel proteolysis by trypsin (Hellman et al., 1995; Rosenfeld et al., 1992) . They were rehydrated with 10 l of 12.5 ng/l trypsin in 25 mM ammonium bicarbonate buffer and digested overnight at 37°C. After digestion, the peptides were extracted 3 times with 50 l of acetonitrile:5% formic acid (1:1). The pooled extracts were dried, redissolved in 10 l acetonitrile:5% formic acid (1:1), diluted 1:1 with ␣-cyano-4-hydroxycinammic acid (Aldrich) matrix and spotted onto a MALDI plate. Samples were analyzed with a Voyager-DE PRO mass spectrometer (Applied Biosystems). Each sample was calibrated internally with peptide fragments from trypsin autocatalytic digestion. The experimental tryptic peptide profiles were compared to the fragments predicted by the sequences of the B1 and B2 ORFs.
Infection of G. mellonella larvae
Larvae of the greater wax moth, G. mellonella (Carolina Biologicals), were reared at 31°C as described . Plasmid-transfected BSR T7/5 cells were incubated as above and harvested by scraping into 500 l PBSM (phosphate buffered saline containing 1 mM each MgCl 2 and CaCl 2 ). Cells were lysed by three cycles of freezing and thawing and cell debris was removed by centrifugation. Lysates (10 l per insect), either left untreated or treated with RNaseA, were injected into the hemocoel of G. mellonella larvae as described for PaV (Johnson and Ball, 2001) , in groups of 12 (average weight, 70 mg). Injected larvae were incubated with food at 31°C for 11 days. For purification of recombinant NoV, incubation was for 8 days and virus particles were isolated as above.
Infection of BHK21 cells with NoV
For the time-course experiments, 2 ϫ 10 6 BHK21 cells were infected in serum-containing growth medium with 1000 particles per cell of authentic, mouse-derived NoV or of recombinant NoV grown in G. mellonella larvae, and incubated at 28°C for 12 days. Parallel wells were harvested at 24 h intervals and total cellular RNAs were isolated and analyzed by Northern blot hybridization as above.
For determination of viral yields from transfected BSR T7/5 cells, cell lysates were prepared 48 h after transfection by three cycles of freezing and thawing as described above, except that cells were harvested in 1 ml PBSM, then treated with RNaseA. Serial 10-fold dilutions were prepared in serum-free medium and used to infect monolayers of 8 ϫ 10 4 BHK21 cells. Infection of BHK21 cells in parallel wells with gradient-purified recombinant NoV, at multiplicities of 2 ϫ 10 4 , 2 ϫ 10 3 , 200, or 20 particles per cell, generated a standard curve. After incubation at 28°C for 5 days, total cellular RNAs were extracted and quantitated by Northern blot hybridization as above.
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